AX

aXichem AB (publ)FNSE aXichem AB Stock Report

Last reporting period 30 Jun, 2023

Updated 21 Oct, 2024

Last price

Market cap $B

0.127

Micro

Exchange

FNSE - First North Sweden

AXIC A.ST Stock Analysis

AX

Uncovered

aXichem AB (publ) is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-50/100

Low score

Market cap $B

0.127

Dividend yield

Shares outstanding

23.62 B

aXichem AB is a biotechnology company. The company is headquartered in Malmo, Skane. The company went IPO on 2008-07-10. The company develops an eco-friendly solution, Phenylcapsaicin. Phenylcapsaicin is a non-toxic antifouling agent, which can be used in the shipping industry, as it keeps vessels free from fouling. Additionally, the Company holds several world patents for alternative uses and applications of phenylcapsaicin. Phenylcapsaicin can be applied as bio-repellent against all living organisms in settings where animals cause damage to human installations. The Company’s products comprise bio-repellents, feed ingredients, food and dietary supplements, which contain synthetically produced and patented capsaicin, traded as aXiphen. The Company’s shareholders are MANAKIN LTD, BLACK ARROW LTD and LMK VENTURES AB, among others.

View Section: Eyestock Rating